Germany Needs More Space for Research and Science
Germany is home to many important companies in the fields of medicine, biology, and pharmacy. This industry is often referred to as "Life Science." Although Germany is a significant location for science, there is a growing problem: there is a lack of suitable buildings and modern laboratories for these specialized companies.
A recent comparison shows a massive difference between Germany and the USA. While only about 85,000 square meters of specialized life science space are available in Germany, there are already 65 million square meters in the USA. These figures make it clear that the German market for research real estate is still very small by international standards.
Experts emphasize that infrastructure is crucial for economic success. Researchers need state-of-the-art workplaces to develop new medicines or technologies. If there is not enough space for these innovations in Germany, young start-ups or large corporations could move their research to other countries.
Despite the current figures, there are also positive prospects. As the demand for medical research increases worldwide, this sector offers great opportunities for investors in Germany. Especially in cities like Munich, Berlin, or Heidelberg, much more is likely to be invested in new laboratory buildings in the future.
In summary, Germany still has a lot of catching up to do in the field of life science real estate. To remain a leading country for science and innovation, the construction of new research centers and laboratories in the coming years is an important task for the economy.